PABLO
ROJO CONEJO
Profesor titular de universidad
Talía
Sainz
Publicacions en què col·labora amb Talía Sainz (5)
2023
-
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
The Lancet Child and Adolescent Health, Vol. 7, Núm. 10, pp. 718-727
-
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
eClinicalMedicine, Vol. 60
2022
-
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
The Lancet HIV, Vol. 9, Núm. 9, pp. e627-e637
-
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
The Lancet HIV, Vol. 9, Núm. 9, pp. e638-e648
2020
-
Longitudinal evolution of vertically HIV/HCV–co-infected vs HCV–mono-infected children
Journal of Viral Hepatitis, Vol. 27, Núm. 1, pp. 61-67